GSKGSK plc同业对比
GSK plc 与Pharmaceutical Preparations的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Pharmaceutical Preparations)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GSK本股 | $216.6B#1 | — | — | — | — | — | — | — | — | — | 24.6%#3 | — |
| GMAB | — | — | — | — | 19.2%#1 | -15.0%#5 | 28.6%#1 | — | — | — | 23.8%#4 | — |
| GNMSF | — | — | — | — | 19.2%#1 | -15.0%#5 | 28.6%#1 | — | — | — | — | — |
| GRCE | $44M#8 | — | 0.9x#1 | 0.4x#1 | — | 18.6%#3 | -11.1%#5 | -16.2%#4 | — | — | -32.4%#7 | — |
| HCM | $12.0B#2 | 26.4x#1 | 9.7x#2 | 21.8x#2 | -13.0%#3 | 1111.0%#1 | -7.1%#3 | 36.9%#1 | 0.0%#1 | — | -21.5%#5 | — |
| HELP | $267M#5 | — | — | — | — | — | — | — | — | — | 106.3%#1 | — |
| HMDCF | — | — | — | — | -13.0%#3 | 1111.0%#1 | -7.1%#3 | 36.9%#1 | 0.0%#1 | — | — | — |
| HSTC | — | — | — | — | — | -0.8%#4 | — | -11.8%#3 | — | — | — | — |
| HYFT | $64M#7 | — | — | — | — | — | — | — | — | — | -27.3%#6 | — |
| IFRX | $152M#6 | — | — | — | — | — | — | — | — | — | 52.2%#2 | — |
| IMMP | $417M#3 | — | — | — | — | — | — | — | — | — | -83.1%#9 | — |
| IMRN | $278M#4 | — | — | — | — | — | — | — | — | — | -34.6%#8 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-09-18。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议